Susan Quaggin reports a stock award at AbbVie

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Quaggin Susan E

Reporting filer

Susan Quaggin reports a stock award, not an open-market purchase or sale, in AbbVie Inc.. Form 4 filed Oct 2, 2026 lists 1 entry.

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Stock Equivalent Units (derivative)	Quaggin Susan E	2026-09-30	A	Grant or award	59	261.59	918	2 days	Filed terms security Title: Stock Equivalent Units conversion Or Exercise Price: 261.59 transaction Date: 2026-09-30 transaction Form Type: 4 transaction Code: A equity Swap Involved: 0 transaction Shares: 59 transaction Price Per Share: 261.59 transaction Acquired Disposed Code: A id: F1 id: F1 underlying Security Title: Common Stock underlying Security Shares: 59 shares Owned Following Transaction: 918 id: F2 direct Or Indirect Ownership: D nature Of Ownership:

Owner: Quaggin Susan E
Date: 2026-09-30
Code: A
Action: Grant or award
Quantity: 59
Price: 261.59
Following holdings: 918
Reporting delay: 2 days
Filed terms and references: Filed terms
security Title: Stock Equivalent Units
conversion Or Exercise Price: 261.59
transaction Date: 2026-09-30
transaction Form Type: 4
transaction Code: A
equity Swap Involved: 0
transaction Shares: 59
transaction Price Per Share: 261.59
transaction Acquired Disposed Code: A
id: F1
id: F1
underlying Security Title: Common Stock
underlying Security Shares: 59
shares Owned Following Transaction: 918
id: F2
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Quaggin Susan E: Director.
F1: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

Prepared automatically from public filing data. Report a correction.